202
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China

, , , , , , , , , & show all
Pages 1723-1736 | Published online: 01 Jul 2019

References

  • World Health Organization. Depression and Other Common Mental Disorders: Global Health Estimates. Geneva: World Health Organization; 2017.
  • Gu L, Xie J, Long J, et al. Epidemiology of major depressive disorder in Mainland China: a systematic review. PLoS One. 2013;8(6):e65356. doi:10.1371/journal.pone.006535623785419
  • Lee S, Tsang A, Huang YQ, et al. The epidemiology of depression in metropolitan China. Psychol Med. 2008;39(5):735–747. doi:10.1017/S003329170800409118713484
  • Lim GY, Tam WW, Lu Y, Ho CS, Zhang MW, Ho RC. Prevalence of depression in the community from 30 countries between 1994 and 2014. Sci Rep. 2018;8(1):2861. doi:10.1038/s41598-018-21243-x29434331
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifthed. DSM-5 Washington DC: American Psychiatric Publishing; 2013.
  • Srisurapanont M, Hong JP, Tian-Mei S, et al. Clinical features of depression in Asia: results of a large prospective, cross-sectional study. Asia Pac Psychiatry. 2013;5(4):259–267. doi:10.1111/appy.1210424038919
  • World Health Organisation. ICD-10 Classifications of Mental and Behavioural Disorder: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organisation; 1992.
  • Srisurapanont M, Bautista D, Chen C-H, Wang G, Udomratn P, Eurviriyanukul K. Subjective memory and concentration deficits in medication-free, non-elderly Asians with major depressive disorder: prevalence and their correlates. J Affect Disord. 2015;171:105–110. doi:10.1016/j.jad.2014.09.00725303026
  • Conradi HJ, Ormel J, de Jonge P. Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychol Med. 2011;41(6):1165–1174. doi:10.1017/S003329171000191120932356
  • Greer TL, Kurian BT, Trivedi MH. Defining and measuring functional recovery from depression. CNS Drugs. 2010;24(4):267–284. doi:10.2165/11530230-000000000-0000020297853
  • Vicent-Gil M, Keymer-Gausset A, Serra-Blasco M, et al. Cognitive predictors of illness course at 12 months after first-episode of depression. Eur Neuropsychopharmacol. 2018;28(4):529–537. doi:10.1016/j.euroneuro.2018.02.00129482974
  • Papakostas GI. Cognitive symptoms in patients with major depressive disorder and their implications for clinical practice. J Clin Psychiatry. 2014;75(1):8–14. doi:10.4088/JCP.13r08710
  • McIntyre RS, Lee Y, Mansur RB. Treating to target in major depressive disorder: response to remission to functional recovery. CNS Spectr. 2015;20(Suppl 1):20–30; quiz 31 DOI:10.1017/S1092852915000826
  • Woo YS, Rosenblat JD, Kakar R, Bahk WM, McIntyre RS. Cognitive deficits as a mediator of poor occupational function in remitted major depressive disorder patients. Clin Psychopharmacol Neurosci. 2016;14(1):1–16. doi:10.9758/cpn.2016.14.1.126792035
  • McIntyre RS, Cha DS, Soczynska JK, et al. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress Anxiety. 2013;30(6):515–527. doi:10.1002/da.2206323468126
  • McIntyre RS, Soczynska JZ, Woldeyohannes HO, et al. The impact of cognitive impairment on perceived workforce performance: results from the international mood disorders collaborative project. Compr Psychiatry. 2015;56:279–282. doi:10.1016/j.comppsych.2014.08.05125439523
  • Hu TW, He Y, Zhang M, Chen N. Economic costs of depression in China. Soc Psychiatry Psychiatr Epidemiol. 2007;42(2):110–116. doi:10.1007/s00127-006-0151-217235441
  • Fehnel SE, Forsyth BH, DiBenedetti DB, Danchenko N, François C, Brevig T. Patient-centered assessment of cognitive symptoms of depression. CNS Spectr. 2013;21(1):43–52. doi:10.1017/S109285291300064324067243
  • Shi C, Wang G, Tian F, et al. Reliability and validity of Chinese version of perceived deficits questionnaire for depression in patients with MDD. Psychiatry Res. 2017;252:319–324. doi:10.1016/j.psychres.2017.03.02128314227
  • Jaeger J. Digit symbol substitution test: the case for sensitivity over specificity in neuropsychological testing. J Clin Psychopharmacol. 2018;38(5):513–519. doi:10.1097/JCP.000000000000094130124583
  • Wechsler D. Wechsler Adult Intelligence Scale. 3rd ed. San Antonio, TX: Psychological Corporation; 1997.
  • McIntyre RS, Harrison J, Loft H, Jacobson W, Olsen CK. The effects of vortioxetine on cognitive function in patients with major depressive disorder: a meta-analysis of three randomized controlled trials. Int J Neuropsychopharmacol. 2016;19(10):pyw055. doi:10.1093/ijnp/pyw055
  • Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry Res. 1960;23(1):56–62. doi:10.1136/jnnp.23.1.56
  • Guy W. Clinical Global Impressions In: Guy W, editor. ECDEU Assessment Manual for Psychopharmacology Revised. Rockville, MD: National Institute of Mental Health; 1976:217–222.
  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613.11556941
  • Mausbach BT, Harvey PD, Goldman SR, Jeste DV, Patterson TL. Development of a brief scale of everyday functioning in persons with serious mental illness. Schizophr Bull. 2007;33(6):1364–1372. doi:10.1093/schbul/sbm01417341468
  • Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics. 1993;4(5):353–365. doi:10.2165/00019053-199304050-0000610146874
  • The EuroQoL Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.10109801
  • Wechsler D. Wechsler Adult Intelligence Scale-Revised. San Antonio, TX: Psychological Corporation; 1981.
  • Bollen KA. Structural Equations with Latent Variables. Hoboken, NJ: Wiley; 1989.
  • Rosseel Y. lavaan: an R Package for structural equation modeling. J Stat Softw. 2012;48(2):36.
  • Mahableshwarkar AR, Zajecka J, Jacobson W, Chen Y, Keefe RS. A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder. Neuropsychopharmacology. 2015;40(8):2025–2037. doi:10.1038/npp.2015.5225687662
  • McIntyre RS, Lophaven S, Olsen CK. A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int J Neuropsychopharmacol. 2014;17(10):1557–1567. doi:10.1017/S146114571400054624787143
  • Rosenblat JD, Kakar R, McIntyre RS. The cognitive effects of antidepressants in major depressive disorder: a systematic review and meta-analysis of randomized clinical trials. Int J Neuropsychopharmacol. 2016;19:2. doi:10.1093/ijnp/pyv082
  • Baune BT, Brignone M, Larsen KG. A network meta-analysis comparing effects of various antidepressant classes on the Digit symbol substitution test (DSST) as a measure of cognitive dysfunction in patients with major depressive disorder. Int J Neuropsychopharmacol. 2017;21(2):97–107.
  • Marino SE, Meador KJ, Loring DW, et al. Subjective perception of cognition is related to mood and not performance. Epilepsy Behav. 2009;14(3):459–464. doi:10.1016/j.yebeh.2008.12.00719130899
  • Srisurapanont M, Suttajit S, Eurviriyanukul K, Varnado P. Discrepancy between objective and subjective cognition in adults with major depressive disorder. Sci Rep. 2017;7(1):3901. doi:10.1038/s41598-017-04353-w28634383
  • Crumley JJ, Stetler CA, Horhota M. Examining the relationship between subjective and objective memory performance in older adults: a meta-analysis. Psychol Aging. 2014;29(2):250–263. doi:10.1037/a003590824955993
  • van der Werf-Eldering MJ, Burger H, Jabben N, Holthausen EAE, Aleman A, Nolen WA. Is the lack of association between cognitive complaints and objective cognitive functioning in patients with bipolar disorder moderated by depressive symptoms? J Affect Disord. 2011;130(1):306–311. doi:10.1016/j.jad.2010.10.00521353309
  • Hammer-Helmich L, Haro JM, Jonsson B, et al. Functional impairment in patients with major depressive disorder: the 2-year PERFORM study. Neuropsychiatr Dis Treat. 2018;14:239–249. doi:10.2147/NDT.S14609829386897
  • Lam RW, Kennedy SH, McLntyre RS, Khullar A. Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment. Can J Psychiatry. 2014;59(12):649–654. doi:10.1177/07067437140590120625702365
  • Larsen KG, Haro JM, Saragoussi D, Hammer-Helmich L. Depression severity and cognitive symptoms are independent predictors of functioning in patients with depression. Eur Neuropsychopharmacol. 2017;27:S806. doi:10.1016/S0924-977X(17)31461-X